Guizhou Sanli Pharmaceutical Co.,Ltd (SHSE:603439) said it plans to acquire 50.26% stake in Pharma firm for CNY 499.6 million ($68.41 million). The company said it will own 75.9% stake in the Pharma firm after the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.53 CNY | +1.41% | +3.64% | -12.45% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.45% | 920M | |
+29.88% | 682B | |
+30.35% | 586B | |
-3.73% | 364B | |
+17.69% | 327B | |
+3.15% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+7.39% | 165B |
- Stock Market
- Equities
- 603439 Stock
- News GuiZhou SanLi Pharmaceutical Co.,Ltd
- Guizhou Sanli Pharma Plans Acquisition for CNY 499.6 Million